Journal of Allergy and Clinical Immunology-In Practice
Scope & Guideline
Bridging research and practice for better patient outcomes.
Introduction
Aims and Scopes
- Clinical Management of Allergies and Asthma:
The journal emphasizes studies that provide insights into the management and treatment of allergic conditions, particularly asthma, highlighting evidence-based strategies and clinical outcomes. - Innovations in Immunotherapy:
A significant focus is on the development and evaluation of new immunotherapies for allergic conditions, including oral and sublingual immunotherapy, and their impact on patient quality of life. - Comorbidities and Their Impact:
Research examining the interplay between allergic diseases and comorbid conditions, such as obesity, cardiovascular disease, and mental health issues, is prominently featured. - Health Disparities in Allergy and Immunology:
The journal addresses the disparities in access to care and treatment outcomes among different populations, promoting equitable healthcare practices. - Emerging Research in Allergic Diseases:
It encompasses novel findings related to the pathophysiology of allergic diseases, including genetic factors, environmental triggers, and the role of the microbiome. - Patient-Centered Approaches:
The journal promotes research that emphasizes patient-reported outcomes, adherence to treatment, and the psychosocial aspects of managing allergies and asthma.
Trending and Emerging
- Biologics and Targeted Therapies:
There is a growing body of research focused on biologics and targeted therapies for severe asthma and other allergic conditions, emphasizing their effectiveness and safety in real-world settings. - Digital Health and Telemedicine:
The integration of digital health solutions and telemedicine into allergy care has become increasingly relevant, particularly in the context of the COVID-19 pandemic, leading to studies on their effectiveness and patient satisfaction. - Food Allergies and Immunotherapy:
Research on food allergies, particularly the efficacy of oral immunotherapy and management strategies, has gained momentum, reflecting a heightened awareness of food allergy prevalence and its impact on quality of life. - Health Equity and Social Determinants of Health:
Emerging discussions around health equity and the impact of social determinants on allergy and asthma outcomes are becoming more prominent, aiming to address disparities in care. - Longitudinal Studies of Asthma and Allergic Conditions:
There is an increasing interest in longitudinal studies that track the progression of asthma and allergies over time, providing valuable insights into long-term management and outcomes.
Declining or Waning
- Traditional Allergy Testing Methods:
There has been a noticeable decrease in studies centered around conventional allergy testing methods, such as skin prick tests, as newer, more innovative diagnostic approaches gain traction. - Generalized Treatment Guidelines:
Research focusing on broad, non-specific treatment guidelines is becoming less common, with a shift towards personalized and precision medicine approaches that cater to individual patient needs. - Drug Allergy Labels and Management:
The frequency of studies solely focused on the management of drug allergy labels is waning, as integrated approaches to allergy management, including the evaluation of multiple allergies, gain more attention. - Environmental Allergens in Isolation:
The exploration of environmental allergens as isolated factors is decreasing, with more emphasis being placed on the complex interactions between multiple allergens and individual patient responses.
Similar Journals
Egyptian Journal of Pediatric Allergy and Immunology
Connecting researchers and practitioners for a healthier future.Welcome to the Egyptian Journal of Pediatric Allergy and Immunology, a leading academic platform dedicated to the advancement of knowledge in the field of pediatric allergy and immunology. Published by the prestigious Egyptian Society of Pediatric Allergy & Immunology, this journal aims to address the pressing challenges and breakthroughs in the diagnosis, treatment, and management of allergic diseases in children. As a crucial resource for researchers, healthcare professionals, and students, it focuses on disseminating high-quality, peer-reviewed articles that contribute to the global understanding of allergic conditions and immunological responses in pediatric populations. Although the journal is currently not an Open Access publication, it provides a valuable gateway to research findings that can shape clinical practice and influence future investigations. With an emphasis on contributing to improved healthcare outcomes for children suffering from allergy and immunology disorders, the Egyptian Journal of Pediatric Allergy and Immunology stands out as an essential reference in the field.
ALLERGY
Pioneering Research in Allergy and Immunological Health.ALLERGY is a leading international journal published by WILEY, dedicated to advancing the understanding of allergic diseases and immunology. With an ISSN of 0105-4538 and an E-ISSN of 1398-9995, this esteemed journal has been at the forefront of the field since its inception in 1948 and continues to publish high-quality research up until 2024. Positioned in the Q1 category for both Immunology and Allergy, ALLERGY ranks impressively within the top percentiles of its categories, underscoring its significant impact, as reflected in its Scopus rankings (#11 out of 233 in Immunology and Allergy, and #14 out of 236 in Immunology and Microbiology). Researchers and practitioners accessing this journal can expect a rigorous selection of peer-reviewed articles that address current challenges, innovative therapies, and advancements in the immunological sciences. Although it is not an open-access journal, ALLERGY remains vital for academics, healthcare professionals, and students alike, fostering a deeper understanding of the mechanisms and treatments associated with allergies.
Allergy & Rhinology
Innovating research for a healthier tomorrow.Allergy & Rhinology, published by SAGE Publications Inc, is a premier open access journal that has been disseminating critical research since 2011. With a dedicated ISSN of 2152-6567 and an E-ISSN of 2152-6567, this journal serves as an essential platform for scholars in the fields of immunology, allergy, and otorhinolaryngology. Recognized in the 2023 Scopus rankings, it holds a Q3 category in Immunology and Allergy and a Q2 category in Otorhinolaryngology, reflecting its commitment to high-quality research. The journal not only supports the sharing of innovative research ideas and practices but also ensures broader access to new developments within these vital fields, appealing to researchers, clinicians, and students alike. With its headquarters in the United Kingdom and an address in Thousand Oaks, California, Allergy & Rhinology continues to contribute significantly to the advancement of knowledge, helping professionals tackle pressing issues related to allergies and respiratory conditions.
CURRENT ALLERGY AND ASTHMA REPORTS
Shaping the Future of Allergy and Asthma ManagementCURRENT ALLERGY AND ASTHMA REPORTS, published by CURRENT MEDICINE GROUP, is a premier journal dedicated to advancing knowledge in the fields of allergy, asthma, and pulmonary medicine. With an impressive impact factor and a distinguished position in the Scopus ranking system—holding the 12th spot in Pulmonary and Respiratory Medicine and 40th in Immunology and Allergy—this journal is vital for researchers, clinicians, and healthcare professionals aiming to stay abreast of the latest developments and evidence-based practices. Since its inception in 2001, the journal has committed to publishing rigorous research articles, reviews, and expert opinion pieces that inform both clinical practice and research initiatives. Although it does not currently offer open access, it continues to maintain a robust platform for disseminating critical findings and fostering scholarly dialogue, ensuring it remains an essential resource for those dedicated to improving patient outcomes in respiratory health.
Allergy Asthma and Clinical Immunology
Advancing knowledge in allergy and asthma research.Allergy Asthma and Clinical Immunology, a pioneering open access journal published by BMC, has been at the forefront of immunological research since its inception in 2005. With an ISSN of 1710-1492, this UK-based journal has established a significant presence in the fields of Immunology, Allergy, and Pulmonary and Respiratory Medicine, achieving notable quartile rankings such as Q2 in Immunology and Allergy in 2023. It plays a crucial role in disseminating high-quality research that advances our understanding of allergy and asthma, making substantial contributions to clinical practices and public health. The journal embraces the principles of Open Access, allowing researchers, professionals, and students from around the globe to access its content freely, thus facilitating knowledge sharing and collaboration within the scientific community. As it converges towards 2024, Allergy Asthma and Clinical Immunology continues to attract impactful studies that drive innovation and improve patient care in the face of rapidly evolving challenges in immunological health.
Current Allergy & Clinical Immunology
Advancing the frontiers of allergy and immunology.Current Allergy & Clinical Immunology is a vital peer-reviewed journal published by the Allergy Society of South Africa, focused on advancing the field of immunology and allergy medicine. With an ISSN of 1609-3607, this journal offers crucial insights and research findings pertinent to the understanding and treatment of allergic conditions. Operating from South Africa, it features contributions from a diverse range of authors and professionals in the field. Published from 2008 to 2024, the journal plays an essential role in disseminating current knowledge, even as it holds a Q4 ranking in Immunology and Allergy and is positioned at the 4th percentile based on Scopus rankings. While not open access, it remains an important resource for researchers, practitioners, and students looking to stay informed on emerging trends and breakthroughs in allergy and clinical immunology.
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY
Connecting researchers and practitioners in Allergy and Immunology.JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY is an esteemed publication dedicated to the fields of Immunology and Allergy, published by ESMON PUBLICIDAD S A in collaboration with the Department of Allergy and Clinical Immunology at the University Clinical Navarra, Spain. With its rich history spanning over three decades since its inception in 1991, this journal has gained prominence in the scientific community, holding a commendable Q2 quartile in Allergy and a Q3 quartile in Immunology. Ranked within the top tiers of its categories according to Scopus, it stands at Rank #80/233 in Immunology and Allergy, and Rank #96/236 in Immunology and Microbiology, indicating its influential role in disseminating cutting-edge research and clinical insights. Though primarily print-focused, the journal strives to bridge gaps in knowledge and contribute to the ongoing dialogue among researchers, professionals, and students in the immunological sciences. The JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY is essential for anyone committed to advancing the understanding of allergic and immunological conditions.
American Journal of Rhinology & Allergy
Fostering collaboration in the pursuit of respiratory wellness.Welcome to the American Journal of Rhinology & Allergy, a leading publication in the fields of otolaryngology and immunology, published by SAGE Publications Inc. Since its inception in 2009, this journal has played a pivotal role in disseminating cutting-edge research and reviews, addressing critical topics related to sinus disease, allergic disorders, and respiratory health. With an impressive Scopus ranking that places it in the top quartiles of both immunology and medicine, the journal garners about a 90th percentile ranking in otorhinolaryngology, reflecting its significance in advancing medical knowledge and clinical practice. The American Journal of Rhinology & Allergy aims to bridge the gap between laboratory research and clinical application, providing a platform for researchers and professionals to explore innovative therapies and treatment protocols. Access options include traditional subscription models to ensure comprehensive support for the academic community. Join our efforts to enhance understanding and treatment in the critical area of rhinology and allergy.
Arthritis & Rheumatology
Empowering Global Collaboration in RheumatologyArthritis & Rheumatology is a leading journal dedicated to the advancement of knowledge in the fields of rheumatology, immunology, and allergy. Published by WILEY in the United Kingdom, this prestigious journal boasts an impressive impact factor and a prominent reputation, ranking in the Q1 category across multiple disciplines, including Immunology and Rheumatology. With its high ranking of 4th out of 73 in Rheumatology and notable standings in related fields, it serves as a crucial platform for researchers, healthcare professionals, and scholars to disseminate groundbreaking findings. The journal embraces an Open Access model, enhancing the accessibility of vital research to a global audience and ensuring that knowledge dissemination is maximized. Since its inception in 2014, Arthritis & Rheumatology has been at the forefront of impactful research, fostering collaboration and innovation in tackling complex challenges within these medical disciplines. Researchers looking to explore the latest advancements and engage with cutting-edge studies in these fields will find this journal to be an essential resource.
CLINICAL AND EXPERIMENTAL ALLERGY
Leading the Charge in Allergy Research ExcellenceCLINICAL AND EXPERIMENTAL ALLERGY is a premier peer-reviewed journal dedicated to advancing the scientific understanding of allergy and immunology. Published by Wiley in the United Kingdom, this esteemed journal maintains a significant impact factor, reflecting its high standards and influential research contributions. With an impressive history since its inception in 1971, the journal is poised to continue leading the discourse in the field until at least 2024. It is ranked in the Q2 quartile for both Immunology and Allergy categories, further highlighting its reputable standing within the academic community. The journal's Scopus rankings showcase its academic relevance, securing the 49th and 51st positions in the Medicine and Immunology categories, respectively. Researchers, professionals, and students will find vital insights and contemporary research trends within its pages, making it an essential resource for those invested in understanding and addressing allergic diseases and disorders.